Alopecia Areata Clinical Trials

239 clinical trials for Alopecia Areata across international registries, including 41 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — RECRUITING · PHASE3
• A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) — RECRUITING · PHASE2
• An Observational Study of Patients With Dermatologic Disease — RECRUITING
• A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata — RECRUITING · PHASE3
• Serum Ferroptosis Biomarkers (GPX4, MDA) in Alopecia Areata — RECRUITING
• Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib — RECRUITING
• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata — RECRUITING · PHASE3
• J5D-MC-FPAC: A Phase 2a, Randomized, Multicenter, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Severe Alopecia Areata — RECRUITING · PHASE2
• Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata — RECRUITING · PHASE2
• Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata — RECRUITING · PHASE2
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata — RECRUITING
• Regeneron AA Multicenter (Dupilumab) — RECRUITING · PHASE2
• A Study of LAD603 in Adults With Alopecia Areata — RECRUITING · PHASE2
• A PHASE 2, RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PROOF OF CONCEPT STUDY TO INVESTIGATE EFFICACY AND SAFETY OF LY4005130 IN ADULT PARTICIPANTS WITH SEVERE ALOPECIA AREATA — RECRUITING · PHASE2
• Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata — RECRUITING · PHASE2
• Association of Serum VEGF-A and VCAM-1 Levels With Nailfold Capilleroscopic Alterations in Alopecia Areata — RECRUITING
• A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata — RECRUITING · PHASE1
• Dupilumab in the Treatment of Pediatric Alopecia Areata — RECRUITING · PHASE2
• A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa — RECRUITING
• CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry — RECRUITING
• CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry — RECRUITING
• PALLAS Laser for Skin Diseases — RECRUITING · NA
• Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome — RECRUITING · PHASE2
• Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study — RECRUITING · PHASE4
• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata — RECRUITING · PHASE3
• Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata — RECRUITING · NA
• A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. — RECRUITING · PHASE1
• HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata — RECRUITING · PHASE1
• Determinants of Chronic Inflammatory Skin Disease Trajectories — RECRUITING
• A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBI-CONTROLLED, PROOF-OF-CONCEPT TRIAL WITH PART B OPEN-LABEL EXTENSION OF ADX-914 FOR THE TREATMENT OF SEVERE ALOPECIA ARESTA (SIGNAL-AA) — RECRUITING · PHASE2
• A PHASE 1B/2A, INTRAINDIVIDUAL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY EFFICACY OF ALD-102 SOLUTION FOR INTRADERMAL INJECTION IN SUBJECTS WITH ALOPECIA AREATA — RECRUITING · PHASE1
• Efficacy and Safety of JAK Inhibitors in Patients With AA: RWE Study — RECRUITING
• Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata — RECRUITING · NA
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, 3- ARM, MULTINATIONAL, MULTICENTER, PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AMLITELIMAB MONOTHERAPY BY SUBCUTANEOUS INJECTION IN ADULT PARTICIPANTS WITH SEVERE ALOPECIA AREATA — RECRUITING · PHASE2
• Systemic Treatments for Alopecia Areata Registry — RECRUITING
• A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, PARALLEL GROUP, PLACEBO-CONTROLLED 60- WEEK STUDY TO EVALUATE THE EFFICACY AND SAFETY OF REZPEGALDESLEUKIN IN TREATMENT OF SEVERE TO VERY SEVERE ALOPECIA AREATA IN ADULT PATIENTS (REZOLVE-AA) — RECRUITING · PHASE2
• A PHASE 3 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND PROGRAM TO EVALUATE EFFICACY AND SAFETY OF UPADACITINIB IN ADULT AND ADOLESCENT SUBJECTS WITH SEVERE ALOPECIA AREATA — RECRUITING · PHASE3
• Skin diseases and the association with addictive diseases — RECRUITING
• A PHASE 3, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF BARICITINIB IN CHILDREN FROM 6 YEARS TO LESS THAN 18 YEARS OF AGE WITH ALOPECIA AREATA — RECRUITING · PHASE3
• A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, PHASE 2 STUDY TO EVALUATE CLINICAL EFFICACY AND SAFETY OF DEUCRAVACITINIB (BMS-986165) IN PARTICIPANTS WITH ALOPECIA AREATA — RECRUITING · PHASE2
• A MULTICENTER, OPEN-LABEL, EXTENSION STUDY TO ASSESS THE LONG-TERM SAFETY AND EFFICACY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA — RECRUITING
• Efficacy of twice daily application of LEO 124249 ointment 30 mg/g for 12 weeks on eyebrow alopecia areata. Exploratory Phase 2a — TERMINATED · PHASE2
• Treatment of therapy resistant Alopecia areata with fumaric acid esters (Fumaderm® and Fumaderm initial®) – an open, single center, non-randomized, pilot study with 40 patients — ACTIVE_NOT_RECRUITING · PHASE2
• A phase 2B, randomized, double-blind, parallel group, placebo-controlled study to evaluate the efficacy and safety of Rezpegaldesleukin in the treatment of severe to very severe alopecia areata in adult patients (Rezolve AA) — TERMINATED · PHASE2
• A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata — NOT_YET_RECRUITING · PHASE1
• Microneedling-Assisted Delivery of Cetirizine Versus Latanoprost in Alopecia Areata — COMPLETED · NA
• Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US — COMPLETED
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata — TERMINATED · PHASE2
• Intralesional Cyclosporine for Alopecia Areata — ACTIVE_NOT_RECRUITING · PHASE1
• Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata — NOT_YET_RECRUITING · PHASE2

Refine this search